发明名称 MICRORNA COMPOUNDS AND METHODS FOR MODULATING MIR-21 ACTIVITY
摘要 Described herein are compositions and methods for the inhibition of miR-21 activity. The compositions have certain nucleoside modification patterns that yield potent inhibitors of miR-21 activity. The compositions may be used to inhibit miR-21, and also to treat diseases associated with abnormal expression of miR-21, such as fibrosis and cancer.
申请公布号 US2015218558(A1) 申请公布日期 2015.08.06
申请号 US201514597676 申请日期 2015.01.15
申请人 Regulus Therapeutics Inc. 发明人 Bhat Balkrishen;Marcusson Eric
分类号 C12N15/113 主分类号 C12N15/113
代理机构 代理人
主权项 1. A compound comprising a modified oligonucleotide consisting of 8 to 22 linked nucleosides, wherein the nucleobase sequence of the modified oligonucleotide is complementary to miR-21 (SEQ ID NO: 1) and wherein the modified oligonucleotide comprises at least 8 contiguous nucleosides of the following nucleoside pattern III in the 5′ to 3′ orientation: (R)X—NB—NQ—NQ—NB—(NQ—NQ—NQ—NB)3—NY—NZ wherein each R is a non-bicyclic nucleoside; X is from 1 to 4; each NB is a bicyclic nucleoside; each NQ is a non-bicyclic nucleoside; NY is a modified nucleoside or an unmodified nucleoside; and each NZ is a modified nucleoside.
地址 San Diego CA US